《粤港澳大湾区发展规划纲要》提出“塑造健康湾区”,其中医疗器械产业是重要一环。在一个国家、两种制度、三个法域及关税区、三种货币流通的粤港澳大湾区推动医疗器械产业协同发展,是史无前例的政策创新试验。该纲要发布两年以来,粤港澳大湾区跨制度之异,推出系列政策和措施,在监管一体化、协同创新、医疗融合以及包括资本、物资、人才在内的产业要素流动方面进行一系列政策试验,加速产业创新、生产和应用进程。目前已形成医疗器械产业协同创新生态体系框架,但在政策实施过程中还存在多处堵点。未来有望通过相关制度创新在试验区的集中试点和完善,加速产业协同创新小生态形成,最终将新模式推广到整个大湾区,延伸产业链至全国乃至全球。
<<The Outline of Development Plan for the Guangdong-Hong Kong-Macao Greater Bay Area(GBA)speaks of “Shaping a Healthy Bay Area”. Among the chains the Medical Device Industry is one of the important links. It is an unprecedented pilot program of policy innovation to promote GBA medical device industry synergy development under one country,two systems,three jurisdictions and customs territories,three currency circulations. Since the Outline Development Plan released in 2019,GBA keeps overcoming institutional differences,conducting policy pilots on integrated supervision,collaborative innovation,medical integration,circulation of industrial factors including capital,supplies and talents,accelerating industrial innovation,production and application process. Now GBA has developed medical device industrial synergy innovation ecology framework,in spite of many blocking points during implemetation processes. Hopefully in the future the institutional innovations would be launched and improved in pilot zones intensively,which will result in acceleration of the industrial synergy innovation small ecology formation. The development models would be promoted to GBA,and the industrial chain would be extended to domestic and international area finally.
<<